Blockade of transforming growth factor‐β signaling enhances oncolytic herpes simplex virus efficacy in patient‐derived recurrent glioblastoma models
Shinichi Esaki(Harvard University), Hiroaki Wakimoto(Center for Cancer Research)
Cited by 39
Related Papers
Human Glioblastoma–Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
|Cancer Research|2009|358
Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells
|Neuro-Oncology|2011|239
Genetic alterations that deregulate RB and PDGFRA signaling pathways drive tumor progression in IDH2-mutant astrocytoma
|Acta Neuropathologica Communications|2023|5